Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing novel monoclonal antibodies to treat severe autoimmune and inflammatory diseases. The company leverages advanced antibody engineering technologies to create next-generation complement therapeutics with improved selectivity and potency. Its lead program, DNTH103, is a monoclonal antibody targeting the classical complement pathway for conditions such as generalized Myasthenia Gravis, Multifocal Motor Neuropathy, and Chronic Inflammatory Demyelinating Polyneuropathy. Based in New York City and Waltham, Massachusetts, Dianthus aims to deliver transformative medicinal therapies by addressing unmet needs in autoimmune treatment.
2 - 10 employees
Founded 2017
𧬠Biotechnology
π Pharmaceuticals
π° $100M Private Equity Round on 2022-04
February 8
Join Dianthus Therapeutics as Director, Corporate Counsel to manage legal matters related to biotechnology operations.
πΊπΈ United States β Remote
π° $100M Private Equity Round on 2022-04
β° Full Time
π΄ Lead
π§ββοΈ General Counsel
January 29
Dianthus Therapeutics seeks an Executive Director to lead medical affairs in APAC. Drive strategy, support clinical development, and build relationships with stakeholders.
πΈπ¬ Singapore β Remote
π° $100M Private Equity Round on 2022-04
β° Full Time
π΄ Lead
π Director
Remote Jobs at Dianthus Therapeutics, Inc.